Magnan Rachel A, Murphy Thomas, Rosenthal Lauren, Prasad Aparna, Chelliah Anjali, Kaufman Stuart, Timchak Donna, McPhillips Lindsey, Siddiqui Saira
From the Division of Pediatric Cardiology, Morristown Medical Center, Atlantic Health System, Morristown, N.J.
Division of Neonatology, Morristown Medical Center, Atlantic Health System, Morristown, N.J.
Pediatr Qual Saf. 2024 Dec 24;10(1):e781. doi: 10.1097/pq9.0000000000000781. eCollection 2025 Jan-Feb.
Lipid screening identifies at-risk patients to facilitate cardiovascular risk reduction. National pediatric guidelines recommend universal lipid screening between 9-11 and 17-21 years of age. We aimed to improve adherence to lipid screening for all age-appropriate outpatient pediatric cardiology visits from a baseline of 35% to 90% between November 2021 and July 2023.
All outpatient visits for patients 9-11 and 17-21 years were included. Chart review and an Epic electronic health record report identified patients screened, lipid test results, and need for further testing. A P-chart was generated. After establishing a baseline for 8 weeks, interventions, including an Epic dot phrase, group and individual feedback, and Epic best practice alert (BPA), were incorporated via plan-do-study-act cycles. Balancing measures included anonymous provider surveys on visit length and experience.
More than 1,700 patient visits were included. At baseline, 35% of all age-appropriate patients were screened. The Epic dot phrase prompted a positive shift with a new mean of 59% screened. Another change occurred after the BPA alert, with an increase in screening to 84%. Lipid screening prompted by this initiative found that 38% of those with testing results in Epic had abnormal results requiring follow-up. Providers did not report a significant change in visit length due to screening.
Quality improvement interventions improved adherence to universal lipid screening guidelines. The Epic dot phrase and BPA facilitated positive shifts. These simple interventions can be spread to other practices to improve adherence to lipid screening and other guidelines.
血脂筛查可识别高危患者,以促进降低心血管疾病风险。国家儿科指南建议在9至11岁以及17至21岁之间进行普遍的血脂筛查。我们的目标是在2021年11月至2023年7月期间,将所有适合年龄的儿科心脏病门诊患者的血脂筛查依从率从35%的基线提高到90%。
纳入所有9至11岁以及17至21岁患者的门诊就诊病例。通过病历审查和Epic电子健康记录报告确定已筛查的患者、血脂检测结果以及进一步检测的需求。生成了一个P控制图。在建立8周的基线后,通过计划-执行-研究-行动循环纳入了干预措施,包括Epic点短语、小组和个人反馈以及Epic最佳实践警报(BPA)。平衡措施包括对提供者进行关于就诊时长和体验的匿名调查。
纳入了超过1700例患者就诊病例。在基线时,所有适合年龄的患者中有35%接受了筛查。Epic点短语促使筛查率出现积极变化,新的平均筛查率为59%。在BPA警报发出后又发生了变化,筛查率提高到了84%。这项举措促使的血脂筛查发现,在Epic中有检测结果的患者中,38%的结果异常,需要进行随访。提供者并未报告因筛查导致就诊时长有显著变化。
质量改进干预措施提高了对普遍血脂筛查指南的依从性。Epic点短语和BPA促成了积极变化。这些简单干预措施可推广到其他医疗机构,以提高对血脂筛查及其他指南的依从性。